Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Share-based Compensation (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Share-based Compensation readings, the most recent being $7.6 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 11.69% to $7.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.8 million, a 10.52% increase, with the full-year FY2025 number at $33.8 million, up 10.52% from a year prior.
  • Share-based Compensation hit $7.6 million in Q4 2025 for Treace Medical Concepts, down from $8.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $9.6 million in Q2 2025 to a low of $402000.0 in Q1 2021.
  • Median Share-based Compensation over the past 5 years was $4.4 million (2023), compared with a mean of $4.7 million.
  • Biggest five-year swings in Share-based Compensation: surged 571.2% in 2021 and later dropped 11.69% in 2025.
  • Treace Medical Concepts' Share-based Compensation stood at $1.3 million in 2021, then soared by 91.03% to $2.5 million in 2022, then soared by 137.73% to $5.9 million in 2023, then soared by 45.69% to $8.6 million in 2024, then dropped by 11.69% to $7.6 million in 2025.
  • The last three reported values for Share-based Compensation were $7.6 million (Q4 2025), $8.0 million (Q3 2025), and $9.6 million (Q2 2025) per Business Quant data.